Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population
RecruitingOBSERVATIONAL
Enrollment
120
Participants
Timeline
Start Date
January 1, 2017
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
Conditions
Adverse Drug Event
Trial Locations (1)
H3T 1C5
RECRUITING
Ben Amor Leila, Montreal
All Listed Sponsors
collaborator
Ciusss de L'Est de l'Île de Montréal
OTHER
lead
St. Justine's Hospital
OTHER
NCT04395326 - Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population | Biotech Hunter | Biotech Hunter